Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder.[L6010,L52145]
Synonyms
Dextroamphetamine adipate
Dexamfetamine
(S)-1-phenyl-2-propylamine
Dextroamphetamine saccharate
(+)-α-methylphenylethylamine
(αS)-α-methylbenzeneethanamine
(+)-amphetamine
(+)-α-methylphenethylamine
Desamfetamina
(S)-amphetamine
Dexamphetamine
(S)-1-phenyl-2-aminopropane
(S)-α-methylbenzeneethanamine
d-amphetamine
Dexanfetamina
Dextroamphetamine sulfate
Dexamfetaminum
(S)-(+)-amphetamine
Dexamfetamina
Dextroamphetamine
(S)-(+)-β-phenylisopropylamine
(+)-(S)-amphetamine
Brand Names
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Dexedrine
Mixed Salts of a Single Entity Amphetamine Product XR
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
